Published on in Vol 3, No 3 (2019): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13411, first published .
Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study

Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study

Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study

Journals

  1. Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, Deshmukh B, Shinde V, Bishayee A, Deshmukh R. The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives. Molecules 2020;25(13):3011 View
  2. Sekandi J, Onuoha N, Buregyeya E, Zalwango S, Kaggwa P, Nakkonde D, Kakaire R, Atuyambe L, Whalen C, Dobbin K. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2021;10(1):e18029 View
  3. Donahue M, Eberly M, Rajnik M. Tele-TB: Using TeleMedicine to Increase Access to Directly Observed Therapy for Latent Tuberculosis Infection. Military Medicine 2021;186(Supplement_1):25 View
  4. Ragan E, Gill C, Banos M, Bouton T, Rooney J, Horsburgh C, Warren R, Myers B, Jacobson K. Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study. JMIR Research Protocols 2021;10(6):e24510 View
  5. Maraba N, Orrell C, Chetty-Makkan C, Velen K, Mukora R, Page-Shipp L, Naidoo P, Mbatha M, Fielding K, Charalambous S. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial. Trials 2021;22(1) View
  6. Zimmer A, Heitkamp P, Malar J, Dantas C, O'Brien K, Pandita A, Waite R. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2021;24:100248 View